Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.
Eva M RempisAlexandra SchnackSarah DeckerVera BraunJohn RubaihayoNazarius Mbona TumwesigyePriscilla BusingyeGundel HarmsStefanie TheuringPublished in: BMC pregnancy and childbirth (2017)
In our study, women on Option B+ showed no difference in ABOs compared to HIV-negative women and to women on ART. We identified several non-HIV/ART-related influencing factors, suggesting an urgent need for improving early risk assessment mechanisms in antenatal care through better screening and triage systems. Our results are encouraging with regard to continued universal scale-up of Option B+ and ART programmes.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- polycystic ovary syndrome
- hiv testing
- hiv aids
- pregnancy outcomes
- risk assessment
- hepatitis c virus
- men who have sex with men
- pregnant women
- emergency department
- south africa
- cervical cancer screening
- healthcare
- breast cancer risk
- skeletal muscle
- metabolic syndrome
- drug induced